Catalys Pacific, LLC
Holdings as of 2026-06-30, filed 2026-08-05
This is history, not a current position. These holdings describe 2026-06-30, and the report became public 36 days later. The portfolio has changed since.
Aggregates
computed from the positions belowPositions reported
2
Value reported by manager
$229.5M
Sum of our stored positions
$229.5M
should match the line above
Disclosure lag
36 d
quarter end to filing
Top 5 concentration
100.0%
of the positions shown
New positions
0
vs previous quarter
Exited
0
vs previous quarter
Option positions
0
puts and calls
Positions
2 largest shown| Issuer | Class | Value | Shares | Type | CUSIP |
|---|---|---|---|---|---|
| Mineralys Therapeutics, Inc. | COM | $213.2M | 7,903,838 | — | 603170101 |
| Phathom Pharmaceuticals, Inc. | COM | $16.2M | 1,493,854 | — | 71722W107 |
Values are shown exactly as filed. Before 2023 managers reported in thousands of dollars and afterwards in whole dollars; the reporting unit is not always determinable from the document, so nothing is converted automatically.
Source: U.S. Securities and Exchange Commission, Form 13F · as of 2026-08-05